New Jersey Health Commissioner Judith Persichilli said the “most recent increase began in August,” citing “anecdotal reports at social gatherings” such as “end-of-summer parties and back-to-school parties.”

The incidents in question transpired in March at The Harborage, a 245-bed long-term care facility adjacent to the Palisades Medical Center in North Bergen where at least 25 residents died from COVID-19.

Dozens, if not hundreds of potential treatments are being developed to combat the virus. According to BioNJ President and CEO Debbie Hart, in New Jersey alone, "the medicine chest of the world," that adds up to roughly 60 separate drugs being explored, but nationally there are concerns the work overall is being guided by politics, and not necessarily science.

The health care providers announced a definitive agreement outlining their intention to integrate the systems, which comes less than a year after the parties signed a letter of intent to explore a strategic partnership.

Leaps by Bayer, the company's impact investment arm, is leading Series D financing in the digital biology company with a $50 million contribution.

The funding will add five Phase 3 through commercial-scale manufacturing suites to the company's campus in Harmans, Md.

An estimated 6 million Americans live with the neurodegenerative conditions. By 2050, that number is expected to rise to nearly 14 million.

The 10-year strategic agreement includes operating an urgent care center at the complex.

The enhanced COVID-19 pairings will provide supplies, education and support materials for residents living with the disease.

The distribution from The Cooper Foundation and the Norcross Foundation will dole out more than 16,000 pieces of PPE to learners in pre-K through high school.

These Garden State providers received the highest designation, scoring 100 out of 100 points, on the annual Human Rights Campaign Foundation assessment, which evaluates policies and practices related to the equity and inclusion of patients, visitors and employees.

The state is sending the opioid-overdose antidote naloxone to 179 Emergency Medical Services teams.